69 related articles for article (PubMed ID: 35762796)
1. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
[TBL] [Abstract][Full Text] [Related]
2.
Clayton NP; Jain A; Halasohoris SA; Pysz LM; Lembirik S; Zumbrun SD; Kane CD; Hackett MJ; Pfefferle D; Smiley MA; Anderson MS; Heine H; Meister GT; Pucci MJ
Antimicrob Agents Chemother; 2021 May; 65(5):. PubMed ID: 33593844
[No Abstract] [Full Text] [Related]
3. Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers.
Tenero D; Bowers G; Rodvold KA; Patel A; Kurtinecz M; Dumont E; Tomayko J; Patel P
Antimicrob Agents Chemother; 2013 Jul; 57(7):3334-9. PubMed ID: 23650164
[TBL] [Abstract][Full Text] [Related]
4. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
Rodvold KA; Danziger LH; Gotfried MH
Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
[TBL] [Abstract][Full Text] [Related]
5. Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.
Connors KP; Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Redican S; Nicolau DP
Antimicrob Agents Chemother; 2014; 58(4):2113-8. PubMed ID: 24468780
[TBL] [Abstract][Full Text] [Related]
6. Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations.
Conte JE; Golden JA; Kipps J; Lin ET; Zurlinden E
Antimicrob Agents Chemother; 2001 Oct; 45(10):2891-6. PubMed ID: 11557486
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, Urinary Excretion, and Pharmaco-Metabolomic Study of Tebipenem Pivoxil Granules After Single Escalating Oral Dose in Healthy Chinese Volunteers.
Li Z; Su M; Cheng W; Xia J; Liu S; Liu R; Sun S; Feng L; Zhu X; Zhang X; Tian X; Qu L
Front Pharmacol; 2021; 12():696165. PubMed ID: 34326771
[TBL] [Abstract][Full Text] [Related]
8.
Gerges B; Rosenblatt J; Shellburne SA; Chaftari AM; Hachem R; Raad I
JAC Antimicrob Resist; 2023 Dec; 5(6):dlad132. PubMed ID: 38089460
[TBL] [Abstract][Full Text] [Related]
9. Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid.
van Hasselt JG; Rizk ML; Lala M; Chavez-Eng C; Visser SA; Kerbusch T; Danhof M; Rao G; van der Graaf PH
Br J Clin Pharmacol; 2016 Jun; 81(6):1113-23. PubMed ID: 26852277
[TBL] [Abstract][Full Text] [Related]
10. Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure.
Sudo K; Kinoshita M; Kawaguchi K; Kushimoto K; Yoshii R; Inoue K; Yamasaki M; Matsuyama T; Kooguchi K; Takashima Y; Tanaka M; Matsumoto K; Tashiro K; Inaba T; Ohta B; Sawa T
Crit Care; 2024 Apr; 28(1):134. PubMed ID: 38654351
[TBL] [Abstract][Full Text] [Related]
11. Systemically Administered Anti-uPAR Antibody Plasma and Lung ELF Pharmacokinetics Characterized by Minimal Lung PBPK Model.
Sharma S; Leonard A; Phoenix K; Chang HY; Wang J; Hansel S
AAPS PharmSciTech; 2023 Nov; 24(8):236. PubMed ID: 37989972
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheep.
Weiss A; Bischof RJ; Landersdorfer CB; Nguyen TH; Davies A; Ibrahim J; Wynne P; Wright P; Ditzinger G; Montgomery AB; Meeusen E; McIntosh MP; Sommer MO
Pharm Res; 2023 Aug; 40(8):1915-1925. PubMed ID: 37498498
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
Ganesan H; Gupta VK; Safir MC; Bhavnani SM; Talley AK; Melnick D; Rubino CM
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0145122. PubMed ID: 37191505
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
Rodvold KA; Bader J; Bruss JB; Hamed K
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
[TBL] [Abstract][Full Text] [Related]
15. Novel Antimicrobial Agents for Gram-Negative Pathogens.
Karvouniaris M; Almyroudi MP; Abdul-Aziz MH; Blot S; Paramythiotou E; Tsigou E; Koulenti D
Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107124
[TBL] [Abstract][Full Text] [Related]
16. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
[TBL] [Abstract][Full Text] [Related]
17. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
